1. Pacini, F. et al. European Thyroid Cancer Taskforce European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 154, 787–803 (2006).
2. Coleman, P. M. et al. Cancer Survival Trends in England and Wales 1971–1995: Deprivation and NHS Region Series SMPS no. 61, London: Stationery Office. 471–478 (1999).
3. Ruggeri, R. M., Campennì, A., Baldari, S., Trimarchi, F. & Trovato, M. What is New on Thyroid Cancer Biomarkers. Biomark Insights. 29(3), 237–252 (2008).
4. Campennì, A. et al. Is Malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? Thyroid. 11, 1607–11 (2014).
5. Giovanella, L., Suriano, S., Maffioli, M., Ceriani, L. & Spriano, G. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck. 32(5), 607–11 (2010).